Absorption Systems Acquires Perry Scientific

Acquisition supports Absorption Systems` mission to move pharma clients through
preclinical testing quickly and efficiently
EXTON, Pa.--(Business Wire)--
Absorption Systems, LP today announced the acquisition of Perry Scientific,
Inc., an in vivo toxicology and pharmacokinetics testing company located in San
Diego, CA. Perry`s research services include testing for toxicology, medical
devices, preclinical models and CNS pharmacology. These services complement
Absorption Systems` portfolio of products and services, which provide definitive
data regarding the absorption, distribution, metabolism and excretion, or ADME
properties, of small molecules in order to help pharmaceutical companies advance
their new drug candidates toward clinical testing and ultimately, regulatory
approval.

"The acquisition of Perry Scientific furthers our mission to efficiently move
clients from the early stages of drug discovery testing for ADME and
pharmacokinetics through the definitive safety and toxicology testing necessary
for new drug and device submissions," commented Patrick M. Dentinger, president
and CEO of Absorption Systems. "By offering a full range of tests, we will be
able to design and perform studies that will get clients to the point of
submission to the FDA as quickly as possible."

In addition to routine preclinical pharmacokinetics testing, Absorption Systems
will conduct studies in compliance with Good Laboratory Practices (GLP) in the
San Diego testing facility, which is fully accredited by the Association for
Assessment and Accreditation of Laboratory Animal Care (AAALAC) International.
Increasingly, pharmaceutical companies are opting to work only with facilities
that are AAALAC accredited. The combined entity will be the only Contract
Research Organization (CRO) in Southern California that can offer a full range
of pharmacokinetic and toxicology studies, including the dose vehicle
development and optimization, dosing and analytical phases of the studies.

Perry Scientific is the oldest and largest CRO in Southern California. It was
founded in 1999 to perform preclinical studies for the biotech and
pharmaceutical industries and has grown to a national company with customers
throughout the U.S.

"Joining forces with Absorption Systems is a natural step in our growth because
our respective businesses are entirely complementary," said Andrew Perry M.D.,
Ph.D., the founder of Perry Scientific. Now we can offer our customers the
convenience and accuracy of having an entire preclinical testing package
performed at a single facility-the combined company offers all the services
needed to move a new drug from the benchtop to the clinic."

About Absorption Systems, LP

Founded in 1996 by Patrick Dentinger and Ismael J. Hidalgo, Ph.D., Absorption
Systems, LP (ASLP) focuses on performing assays (analyses) that can predict the
Absorption, Distribution, Metabolism and Excretion (ADME) of small molecules
using a variety of in vitro, in situ, and in vivo models. ASLP supports these
assays with state of the art bioanalytical capabilities and preclinical
formulation services. For more information visit: www.absorption.com

Absorption Systems, L.P.
Chris Bode, Ph.D., 1-610-280-1451
cbode@absorption.com
www.absorption.com
or
Schwartz Communications
Andrea tenBroek or Wendy Mejia, 1-781-684-0770
absorptionsystems@schwartz-pr.com

Copyright Business Wire 2009